MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

Search

Alcon Inc

Avatud

SektorTervishoid

77.48 2.69

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

75.02

Max

77.48

Põhinäitajad

By Trading Economics

Sissetulek

-167M

183M

Müük

123M

2.6B

P/E

Sektori keskmine

34.31

35.739

Dividenditootlus

0.45

Kasumimarginaal

7.058

Töötajad

25,000

EBITDA

-213M

250M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+30.32% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

0.45%

3.08%

Järgmine tulemuste avaldamine

11. nov 2025

Turustatistika

By TradingEconomics

Turukapital

-7.2B

37B

Eelmine avamishind

74.79

Eelmine sulgemishind

77.48

Uudiste sentiment

By Acuity

50%

50%

149 / 371 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

Alcon Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

2. sept 2025, 23:07 UTC

Omandamised, ülevõtmised, äriostud

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

20. aug 2025, 17:21 UTC

Tulu
Suurimad hinnamuutused turgudel

Alcon Shares Sink After Cut to Fiscal Year Sales Guidance

20. aug 2025, 08:46 UTC

Tulu
Suurimad hinnamuutused turgudel

Alcon Shares Fall After Guidance Trim on U.S. Trade Tariff Hit

5. aug 2025, 10:10 UTC

Omandamised, ülevõtmised, äriostud

Alcon to Buy Staar Surgical for $1.5 Billion

14. mai 2025, 15:56 UTC

Tulu
Suurimad hinnamuutused turgudel

Alcon Shares Fall After Lowering 2025 Outlook

26. sept 2025, 21:56 UTC

Omandamised, ülevõtmised, äriostud

Staar Surgical, Insight Enterprises, and More Stocks See Action From Activist Investors -- Barrons.com

22. sept 2025, 11:15 UTC

Omandamised, ülevõtmised, äriostud

STAAR Surgical Announces Expiration of 'Window Shop' Period; No Competing Acquisition Proposals Received

16. sept 2025, 13:12 UTC

Omandamised, ülevõtmised, äriostud

Staar Surgical Board Believes Value Provided by Alcon Merger Exceeds What STAAR Could Achieve on Standalone Basis in Foreseeable Future >STAA

16. sept 2025, 13:12 UTC

Omandamised, ülevõtmised, äriostud

STAAR Board Unanimously Determined Proposed Merger With Alcon Is in Best Interests of Co, Stockholders >STAA

16. sept 2025, 13:11 UTC

Omandamised, ülevõtmised, äriostud

Staar Surgical Will Hold Special Meeting of Stockholders on Oct 23 >STAA

16. sept 2025, 13:10 UTC

Omandamised, ülevõtmised, äriostud

STAAR Surgical Bd of Directors Unanimously Believes Alcon Merger Maximizes Value for STAAR Stockholders

20. aug 2025, 17:06 UTC

Tulu
Suurimad hinnamuutused turgudel

Alcon Shares Sink After Cut to FY Sales Guidance

19. aug 2025, 20:32 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Alcon Cuts 2025 View To Sales $10.3B-$10.4B >ALC.EB

19. aug 2025, 20:31 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Alcon 2Q EPS 35c >ALC.EB

19. aug 2025, 20:30 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Alcon 2Q Sales $2.58B >ALC.EB

19. aug 2025, 20:30 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Alcon Reports Second-Quarter 2025 Results, Launched Tryptyr And Announced Acquisition Of STAAR Surgical >ALC

8. aug 2025, 13:40 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Staar Surgical's Top Holder Questions Deal -- Market Talk

5. aug 2025, 05:07 UTC

Omandamised, ülevõtmised, äriostud

Alcon Deal Puts STARR Equity Value at Approximately $1.5 Billion. >ALC.EB

5. aug 2025, 05:07 UTC

Omandamised, ülevõtmised, äriostud

Alcon Will Purchase All Outstanding Shares of STAAR Common Stock for $28 Per Share in Cash >ALC.EB

5. aug 2025, 05:07 UTC

Omandamised, ülevõtmised, äriostud

Alcon Deal Represents 51% Premium to Closing Price of STAAR Common Stock on Aug. 4 >ALC.EB

5. aug 2025, 05:07 UTC

Omandamised, ülevõtmised, äriostud

Alcon Agrees to Acquire STAAR Surgical >ALC STAA

5. aug 2025, 05:01 UTC

Omandamised, ülevõtmised, äriostud

Alcon Agrees To Acquire STAAR Surgical >ALC STAA

7. juuli 2025, 12:00 UTC

Omandamised, ülevõtmised, äriostud

Alcon To Acquire LumiThera And Its Photobiomodulation Device For The Treatment Of Early And Intermediate Dry Age-Related Macular Degeneration (AMD) >ALC

30. mai 2025, 06:32 UTC

Market Talk
Tulu

Alcon's First FDA Approval Since Listing Is Positive, But Expected -- Market Talk

22. mai 2025, 20:46 UTC

Omandamised, ülevõtmised, äriostud

Alcon and Lensar Receive FTC Requests for Additional Information About Merger

13. mai 2025, 20:32 UTC

Tulu

Alcon Raises 2025 View To Sales $10.4B-$10.5B >ALC.EB

13. mai 2025, 20:31 UTC

Tulu

Alcon 1Q Sales $2.45B >ALC.EB

13. mai 2025, 20:30 UTC

Tulu

Alcon 1Q Rev $2.47B >ALC.EB

13. mai 2025, 20:30 UTC

Tulu

Alcon 1Q EPS 70c >ALC.EB

8. apr 2025, 08:20 UTC

Market Talk

Med-Tech Investors Seek 'Safe Havens' Amid Tariff Fears -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Alcon Inc Prognoos

Hinnasiht

By TipRanks

30.32% tõus

12 kuu keskmine prognoos

Keskmine 97.88 USD  30.32%

Kõrge 119.297 USD

Madal 77.53 USD

Põhineb 18 Wall Streeti analüütiku instrumendi Alcon Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

18 ratings

13

Osta

5

Hoia

0

Müü

Tehniline skoor

By Trading Central

95.77 / 97.61Toetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Keskpikk perspektiiv

Strong Bullish Evidence

Pikk perspektiiv

Strong Bullish Evidence

Sentiment

By Acuity

149 / 371 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Alcon Inc

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
help-icon Live chat